NFE2L3 and carcinoma: Knockdown of NFE2L3 inhibits cell proliferation and migration, arrests cell cycle at G0/G1 phase and induces cell apoptosis, thereby inhibiting the malignant growth of subcutaneous carcinoma xenograft. Deficiency of NFE2L3 decrease the process of EMT.